Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.0 is now shown, replacing v3.4.3. No study content or navigation changes are evident.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to study data, criteria, or listed locations are evident.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page shows a minor metadata revision from v3.4.0 to v3.4.1; no user-facing content or functionality appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 label on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check103 days agoChange DetectedLocations section updated to consolidate all study sites under a single 'Locations' heading, adding California, Connecticut, Florida, Illinois, Maryland, New York, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, and Quebec. Individual state location headings were removed in favor of a unified Locations list.SummaryDifference1%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.